Numinus Wellness (OTCQX:NUMIF) reported a decline in Q2 2024 revenue to $3.66 million from $3.89 million in Q2 2023, amid clinic reshuffling and industry trends. The company's cash position decreased to $4.8 million from $14.33 million year-over-year. Despite reduced revenues and gross profit, Numinus saw a decrease in G&A expenses and total expenses, leading to a smaller net loss compared to the same period in 2023. The company is focusing on profitability and has initiated cost containment measures, including discontinuing its unprofitable Phoenix clinic and reducing headcount by 60%. Numinus is also exploring strategic alternatives for its Canadian operations to focus on growth opportunities in the U.S., where it generated 88% of its revenue in FY2023.